GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
Strengthening U.S. Biodefense ATLANTA, GA - March 3, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a leader in ...
EQS-News: GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
Alignment with National Health Security Goals: GeoVax’s focus on U.S.-based vaccine production supports HHS’s priority of reducing dependency on foreign pharmaceutical supply chains, ensuring ...